现代死亡风险评分可准确且等同预测真实世界肾下腹主动脉瘤破裂术后死亡率
本研究回顾性分析2011至2019年在本中心因肾下腹主动脉瘤破裂接受手术的49例患者,比较HMC、DAS和VSGNE三种评分对院内死亡的预测价值。结果显示三种评分预测能力相似,HMC评分曲线下面积0.74,VSGNE为0.73,DAS为0.67;HMC评分因使用术前变量更适用于术前评估。
要点
- HMC、VSGNE和DAS评分均能充分预测肾下腹主动脉瘤破裂术后院内死亡,AUC分别为0.74、0.73和0.67。
- HMC与VSGNE评分与院内死亡率呈线性关系(R²分别为0.97和0.93),评分越高死亡可能性越大。
- HMC评分采用术前变量,更适用于术前预后判断。
核心结论
- HMC、VSGNE和DAS评分对肾下腹主动脉瘤破裂术后院内死亡预测表现相似且充分,HMC评分因使用术前变量更适合术前评估。
研究设计与样本
- 回顾性队列研究,纳入2011年1月1日至2019年11月27日在本中心因肾下腹主动脉瘤破裂接受手术的49例患者,其中33例接受腔内修复,16例接受开放修复。
主要发现
- 院内死亡率为37%,其中腔内修复为24%,开放修复为63%。
- HMC和VSGNE评分与院内死亡率呈线性关系,R²分别为0.97和0.93。
- 逻辑回归显示,HMC评分组分中肌酐大于2.0 mg/dL与院内死亡显著相关(OR 12.3,95%CI 1.1-131.7),VSGNE组分中肾上主动脉阻断与院内死亡显著相关(OR 5.5,95%CI 1.2-25.5)。
- HMC、VSGNE和DAS的AUC分别为0.74(95%CI 0.60-0.88)、0.73(95%CI 0.58-0.87)和0.67(95%CI 0.51-0.83)。
临床怎么用
- 对于肾下腹主动脉瘤破裂患者,可使用HMC、VSGNE或DAS评分进行术后死亡风险分层,其中HMC评分适用于术前评估。
局限性
- 本研究为单中心回顾性研究,样本量较小(最终分析49例),且部分患者因选择舒适治疗或缺失关键变量被排除。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: It is often unclear which patients presenting with a ruptured abdominal aortic aneurysm (rAAA) are likely to survive after surgery. The Harborview Medical Center (HMC), Dutch Aneurysm Score (DAS), and Vascular Study Group of New England (VSGNE) risk scores have been recent attempts at predicting mortality in this setting. We compared the prognostic value of these scoring systems for patients at our institution with rAAA. METHODS: A retrospective chart review was performed for all patients who received surgery at our institution for rAAA between January 1, 2011, and November 27, 2019. The χ2, Fisher's exact, and t-tests were used to screen preoperative variables against in-hospital mortality. HMC, DAS, and VSGNE scores were calculated for each patient and tested against in-hospital mortality. Logistic regression and receiver operating characteristic curves were used to assess performance of each scoring system. RESULTS: Sixty-four patients were identified during the study period. Fifteen patients were excluded because 4 patients chose comfort care and an additional 11 patients were missing key variables. The final cohort for analysis included 49 patients who underwent surgery, including 33 patients receiving endovascular repair and 16 patients receiving open repair. The in-hospital mortality was 37% (24% for endovascular repair vs 63% for open repair). Individual variables associated with in-hospital mortality were lowest preoperative systolic blood pressure (P = .036), creatinine greater than 2.0 mg/dL (P = .020), first recorded intraoperative pH (P = .007), and use of suprarenal aortic control (P = .025), and preoperative cardiac arrest approached significance (P = .051). Plots of the HMC and VSGNE scores vs in-hospital mortality rate produced linear relationships (R2 = 0.97 and R2 = 0.93, respectively), in which a higher score was associated with a greater likelihood of mortality. On logistic regression analysis using HMC score components, creatinine greater than 2.0 mg/dL produced a significant association with in-hospital mortality (odds ratio, 12.3; 95% confidence interval [CI], 1.1-131.7). Similar analysis using VSGNE components produced a significant association between suprarenal aortic control and in-hospital mortality (odds ratio, 5.5; 95% CI, 1.2-25.5). receiver operating characteristic curves produced an area under the curve of 0.74 (95% CI, 0.60-0.88), 0.73 (95% CI, 0.58-0.87), and 0.67 (95% CI, 0.51-0.83) for the HMC, VSGNE, and DAS, respectively. CONCLUSIONS: The HMC, VSGNE, and DAS scores performed similarly and adequately predicted in-hospital mortality after rAAA. The HMC score holds the added benefit of using preoperative variables, setting it apart as a valid prognostic indicator in the preoperative setting.
引用
- Ciaramella MA, Ventarola D, Ady J, et al. Modern mortality risk stratification scores accurately and equally predict real-world postoperative mortality after ruptured abdominal aortic aneurysm. J Vasc Surg. 2020. PMID: 32707391. doi:10.1016/j.jvs.2020.07.058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。